Total Payments
$17,790
2023 Payments
$1,187
Companies
46
Transactions
428
Medicare Patients
2,841
Medicare Billing
$172,535
Payment Breakdown by Category
Food & Beverage$17,597 (98.9%)
Consulting$150.00 (0.8%)
Education$43.69 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,597 | 421 | 98.9% |
| Consulting Fee | $150.00 | 1 | 0.8% |
| Education | $43.69 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,446 | 38 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $2,030 | 33 | $0 (2023) |
| Amgen Inc. | $1,264 | 42 | $0 (2021) |
| Novo Nordisk Inc | $1,118 | 32 | $0 (2023) |
| PFIZER INC. | $780.76 | 24 | $0 (2020) |
| AbbVie Inc. | $743.28 | 30 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $732.00 | 16 | $0 (2019) |
| Medtronic Vascular, Inc. | $714.51 | 5 | $0 (2020) |
| Gilead Sciences, Inc. | $680.78 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $545.60 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,187 | 17 | AstraZeneca Pharmaceuticals LP ($363.37) |
| 2022 | $2,396 | 36 | AstraZeneca Pharmaceuticals LP ($477.17) |
| 2021 | $2,934 | 50 | Medtronic, Inc. ($506.01) |
| 2020 | $1,999 | 40 | AstraZeneca Pharmaceuticals LP ($346.32) |
| 2019 | $2,821 | 77 | SANOFI-AVENTIS U.S. LLC ($455.88) |
| 2018 | $3,182 | 93 | SANOFI-AVENTIS U.S. LLC ($483.37) |
| 2017 | $3,270 | 115 | SANOFI-AVENTIS U.S. LLC ($834.07) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/09/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes Care | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $96.09 | General |
| 06/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardio-renal | ||||||
| 05/24/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $72.00 | General |
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $90.46 | General |
| Category: Cardiovascular | ||||||
| 04/27/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $127.00 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/27/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $60.71 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/19/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: Urology | ||||||
| 03/08/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: Respiratory | ||||||
| 02/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 02/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 01/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.13 | General |
| 12/16/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $103.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: ANTIBIOTIC | ||||||
| 11/29/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $98.43 | General |
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $114.05 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 405 | 493 | $93,513 | $19,673 |
| 2022 | 13 | 858 | 1,251 | $160,121 | $59,734 |
| 2021 | 12 | 677 | 1,019 | $113,243 | $41,944 |
| 2020 | 15 | 901 | 1,360 | $162,461 | $51,184 |
Total Patients
2,841
Total Services
4,123
Medicare Billing
$172,535
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 120 | $43,560 | $7,546 | 17.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $13,392 | $4,199 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $17,374 | $3,658 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 60 | $15,360 | $2,345 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 116 | 157 | $1,099 | $1,059 | 96.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $385.00 | $314.27 | 81.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $861.00 | $193.20 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $656.00 | $156.60 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 16 | $640.00 | $135.20 | 21.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 31 | $186.00 | $68.20 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 345 | $80,040 | $24,219 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $27,528 | $13,697 | 49.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 72 | $22,392 | $8,692 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 78 | $12,324 | $4,029 | 32.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $6,230 | $3,893 | 62.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $2,880 | $1,635 | 56.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 220 | 404 | $2,828 | $1,193 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $875.00 | $686.74 | 78.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $840.00 | $660.76 | 78.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 40 | $1,400 | $392.73 | 28.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 30 | 32 | $1,536 | $307.05 | 20.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 13 | $834.00 | $174.96 | 21.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 53 | 69 | $414.00 | $153.22 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 156 | 255 | $59,160 | $19,436 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 84 | 84 | $20,832 | $10,399 | 49.9% |
About Dr. Monica Schmidt, D.O
Dr. Monica Schmidt, D.O is a Family Medicine healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1699904888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monica Schmidt, D.O has received a total of $17,790 in payments from pharmaceutical and medical device companies, with $1,187 received in 2023. These payments were reported across 428 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($17,597).
As a Medicare-enrolled provider, Schmidt has provided services to 2,841 Medicare beneficiaries, totaling 4,123 services with total Medicare billing of $172,535. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Grand Rapids, MI
- Active Since 07/08/2009
- Last Updated 06/24/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699904888
Products in Payments
- FARXIGA (Drug) $1,254
- ELIQUIS (Drug) $1,001
- UBRELVY (Drug) $516.66
- RYBELSUS (Drug) $497.91
- BREZTRI (Drug) $488.88
- NURTEC ODT (Drug) $464.95
- SOLIQUA (Drug) $442.64
- Vascepa (Drug) $428.65
- Aimovig (Biological) $414.34
- INVOKANA (Drug) $391.90
- TOUJEO (Drug) $389.70
- Kerendia (Drug) $377.48
- PRALUENT (Drug) $377.08
- DIABETES - DISEASE (Drug) $373.46
- NEXLIZET (Drug) $356.85
- XARELTO (Drug) $334.08
- LINQ II (Device) $333.52
- EVENITY (Biological) $311.14
- Yupelri (Drug) $308.73
- Repatha (Biological) $288.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Grand Rapids
Mary Dagen, M.d, M.D
Family Medicine — Payments: $162,324
Family Medicine $162,324
Oren Mason, M.d, M.D
Family Medicine — Payments: $118,364
Family Medicine $118,364
Magalis Llovet, Md, MD
Family Medicine — Payments: $21,470
Family Medicine $21,470
Michael Septer, D.o, D.O
Family Medicine — Payments: $14,914
Family Medicine $14,914
Dr. Stephen Cahill, D.o, D.O
Family Medicine — Payments: $14,765
Family Medicine $14,765
Dr. Jeffrey Vanwingen, M.d, M.D
Family Medicine — Payments: $13,853
Family Medicine $13,853